| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 11,894,683 | 11,889,383 |
| Net change in cash | 7,284,293 | 8,367,205 |
| Cash and cash equivalents at beginning of period | 63,741 | - |
| Cash and cash equivalents at end of period | 7,348,034 | - |
Klotho Neurosciences, Inc. (KLTOW)
Klotho Neurosciences, Inc. (KLTOW)